Lenacapavir could put the end of the HIV epidemic in reach — if the people who need it can access it. Here’s one way to make ...

April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that a Phase II Clinical Trial of ...

Jeffrey Okoro, of CFK Africa, tells Rachel Hagan that the drug lenacapavir can be transformative, but Kenya’s rollout is not ...

Introduction Treatment interruption (TI), defined as >28 days late for antiretroviral therapy appointment, is one of the ...

Central Iowa authorities are analyzing a "suspicious device with energetic materials" found inside a backpack left along a ...

“Prior studies have looked at diabetes risk in new users of integrase strand transfer inhibitors,” Hwang explained. “Our ...

Against this backdrop, in collaboration with International Human Virology of Nigeria (IHVN) and other partners, the NTLCP organised a medical outreach on Saturday in Mabushi, a rural community within ...

A new study from the Kwon Lab at the Ragon Institute, published in Cell Host & Microbe, provides the most detailed picture yet of how a promising bacterial therapy works to prevent recurrent bacterial ...

Florida Gov. Ron DeSantis signed legislation providing $31 million in stopgap funding for the state's AIDS Drug Assistance ...

Florida law restores HIV/AIDS medications for thousands who’d been cut from the rolls. Widely used Biktarvy won’t be covered ...

Findings identify genes that may represent possible new targets for a "block and lock" strategy for curing HIV.

Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on ...